Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06320808 · ClinicalTrials.gov registry record · NA
Evaluating FDA's Proposed Patient Medication Information Handout
A NA study, sponsored by Carnegie Mellon University.
- Completed
- Registry status
- NA
- Development phase
- 330
- Enrollment target
NCT06320808 is a NA study that has completed, run by Carnegie Mellon University. The registered enrollment target is 330 participants.
The verdict
NCT06320808, a NA study, has completed, sponsored by Carnegie Mellon University.
- COMPLETED
- Registry status
- NA
- Development phase
- 330 participants
- Enrollment target
Study Summary
The goal of this study is to assess how useful the proposed one-page FDA-template PMI is to potential users. The main questions it aims to answer are: How does the proposed one-page FDA-template PMI compare with the current drug information insert in terms of usefulness and comprehension? and How does the proposed one-page FDA-template PMI compare with a revision adding drug benefit information? Participants will randomized to review one of three patient medication information sheets and then asked questions related to usefulness and comprehension.
Interventions
- OTHER FDA template PMI
- OTHER Decision Critical PMI
- OTHER Standard Information
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 330 participants |
| Start Date | 2024-03-03 |
| Est. Completion | 2025-02-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06320808
The ClinicalTrials.gov registry entry for NCT06320808 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 330 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Carnegie Mellon University, which has 37 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which FDA template PMI is the first listed.
NCT06320808 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06320808 about?
NCT06320808 is a clinical study titled "Evaluating FDA's Proposed Patient Medication Information Handout". The goal of this study is to assess how useful the proposed one-page FDA-template PMI is to potential users. The main questions it aims to answer are: How does the proposed one-page FDA-template PMI compare with the current drug information insert in terms of usefulness and comprehension? and Ho...
What is the current status of trial NCT06320808?
This trial is currently completed. It is a NA study. The enrollment target is 330 participants. The study started on 2024-03-03. Estimated completion is 2025-02-06.
What interventions are being tested in trial NCT06320808?
The interventions under investigation include: FDA template PMI (OTHER), Decision Critical PMI (OTHER), Standard Information (OTHER).
Who is sponsoring clinical trial NCT06320808?
This trial is sponsored by Carnegie Mellon University, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.